Standardized Discharge Planning Tool Leads to Earlier Discharges and Fewer Readmissions
- PMID: 33734187
- DOI: 10.1097/NCQ.0000000000000558
Standardized Discharge Planning Tool Leads to Earlier Discharges and Fewer Readmissions
Abstract
Background: In an inpatient setting, aspects of discharge planning are often left to the provider's memory, leading to errors, inefficiencies, and avoidable costs.
Methods: A multidisciplinary team of oncology practitioners used process improvement methodologies to redesign the discharge planning process.
Interventions: The primary intervention was an evidence-based discharge planning tool, called the discharge navigator, used from admission through discharge.
Results: Thirty-day unplanned readmission rates decreased by 29.0% from preimplementation (March 2017 through August 2017) to postimplementation (September 2017 through March 2020). The percentage of patients discharged before noon increased 76.2%. A comparable service not utilizing the intervention saw lesser or no improvement in these measures.
Conclusion: The tool provided a systematic approach to discharge planning. Key design elements included a centralized location within the electronic health record and an electronic shortcut to populate the tool. Although developed for a specialized population, most elements are applicable to any hospitalized patient.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- Hembree TN, Thirlwell S, Reich RR, Pabbathi S, Extermann M, Ramsakal A. Predicting survival in cancer patients with and without 30-day readmission of an unplanned hospitalization using a deficit accumulation approach. Cancer Med. 2019;8(15):6503–6518. doi:10.1002/cam4.2472
-
- Spring L, Li S, Soiffer RJ, Antin JH, Alyea EP, Glotzbecker B. Risk factors for readmission after allogeneic hematopoietic stem cell transplantation and impact on overall survival. Biol Blood Marrow Transplant. 2015;21(3):509–516. doi:10.1016/j.bbmt.2014.11.682
-
- Bejanyan N, Bolwell BJ, Lazaryan A, et al. Risk factors for 30-day hospital readmission following myeloablative allogeneic hematopoietic cell transplantation (allo-HCT). Biol Blood Marrow Transplant. 2012;18(6):874–880. doi:10.1016/j.bbmt.2011.10.032
-
- Bailey MK, Weiss AJ, Barret ML, Jing J. Characteristics of 30-Day All-Cause Hospital Readmissions, 2010-2016. AHRQ; 2019. Statistical Brief No. 248. Accessed October 20, 2020. https://www.ncbi.nlm.nih.gov/books/NBK538941
-
- FAQ: how and why we rank and rate hospitals. U.S. News & World Report. July 28, 2020. Accessed October 20, 2020. https://health.usnews.com/health-care/best-hospitals/articles/faq-how-an...
MeSH terms
LinkOut - more resources
Full Text Sources